{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:00:35Z","timestamp":1772132435605,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Karamanoglu Mehmetbey University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Odontology"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ki67 is one of the preferred markers to provide standardization in the diagnosis\/grading of oral potentially malignant disorder (OPMD) and oral squamous cell carcinoma (OSCC) in histopathological examinations. The aim of this systematic review is to evaluate the methodologies, findings and interpretations of Ki67 expression studies used in histopathological examinations for the diagnosis and grading of oral epithelial dysplasia (OED), OPMD (oral lichen planus, oral leukoplakia, erythroplakia, oral submucous fibrosis, and oral epithelial dysplasia) and OSCC cases in the literature. Articles in the Web of Science, Pubmed and Scopus databases within the last 5\u00a0years (2020\u20132024) were searched with the related keywords. The modified Quality in Prognosis Studies (QUIPS) tool was used to assess the \u201crisk of bias\u201d of the articles included. 50 articles were included in the systematic review. General risk of bias assessment of the articles included in the review, it was determined that the studies were high risk in terms of selection bias and performance bias, medium risk in terms of detection bias, and low risk in terms of attrition bias and reporting bias. Although it is generally possible to distinguish NM &amp; OED with Ki67 expression, it may be more challenging than comparing NM &amp; OSCC. Ki67 expression is not considered successful in determining the metastatic and recurrence potential of OSCC and OPMD. Ki67 expression may be lower in oral submucous fibrosis (OSMF) than in other types of OPMD, and the most important reason for this may be the proliferative activity change characterized by the typical atrophic epithelium of OSMF.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s10266-026-01344-0","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:11:49Z","timestamp":1772129509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of KI67 as a marker in the diagnose and grading evaluation of oral potentially malignant disorder and oral squamous cell carcinoma: a systematic review"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5863-5928","authenticated-orcid":false,"given":"Samed","family":"Satir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5758-1487","authenticated-orcid":false,"given":"Edanur","family":"Tavmasat Mercantas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"1344_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ijc.2910310104","volume":"31","author":"J Gerdes","year":"1983","unstructured":"Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983;31:13\u201320. https:\/\/doi.org\/10.1002\/ijc.2910310104.","journal-title":"Int J Cancer"},{"key":"1344_CR2","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","volume":"133","author":"J Gerdes","year":"1984","unstructured":"Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133:1710\u20135.","journal-title":"J Immunol"},{"key":"1344_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113414","volume":"23","author":"Z Meng","year":"2022","unstructured":"Meng Z, Li Z, Guo S, et al. MED1 ablation promotes oral mucosal wound healing via JNK signaling pathway. Int J Mol Sci. 2022;23:13414. https:\/\/doi.org\/10.3390\/ijms232113414.","journal-title":"Int J Mol Sci"},{"key":"1344_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9690047","volume":"2021","author":"EA Arafat","year":"2021","unstructured":"Arafat EA, El-Khair SMA, Elsamanoudy AZ, Shabaan DA. Study of the possible alleviated role of atorvastatin on irinotecan-induced lingual mucosal damage: histological and molecular study. Oxid Med Cell Longev. 2021;2021:9690047. https:\/\/doi.org\/10.1155\/2021\/9690047.","journal-title":"Oxid Med Cell Longev"},{"key":"1344_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/life14040459","volume":"14","author":"M Chantiri","year":"2024","unstructured":"Chantiri M, Nammour S, El Toum S, Zeinoun T. Histological and immunohistochemical evaluation of Rh-BMP2: effect on gingival healing acceleration and proliferation of human epithelial cells. Life. 2024;14:459. https:\/\/doi.org\/10.3390\/life14040459.","journal-title":"Life"},{"key":"1344_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/jop.13463","volume":"52","author":"W Li","year":"2023","unstructured":"Li W, Xu X, Ma Z, et al. LncRNA BANCR promotes oral squamous cell carcinoma progression via regulating Rab1A signaling. J Oral Pathol Med. 2023;52:727\u201337. https:\/\/doi.org\/10.1111\/jop.13463.","journal-title":"J Oral Pathol Med"},{"key":"1344_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/odi.14367","volume":"30","author":"KL Zou","year":"2024","unstructured":"Zou KL, Lan Z, Cui H, Zhao YY, Wang WM, Yu GT. CD24 blockade promotes anti-tumor immunity in oral squamous cell carcinoma. Oral Dis. 2024;30:163\u201371. https:\/\/doi.org\/10.1111\/odi.14367.","journal-title":"Oral Dis"},{"key":"1344_CR8","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1002\/cam4.2965","volume":"9","author":"Y Luo","year":"2020","unstructured":"Luo Y, Li W, Ling Z, et al. ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine-addicted OSCC cells. Cancer Med. 2020;9:3489\u201399. https:\/\/doi.org\/10.1002\/cam4.2965.","journal-title":"Cancer Med"},{"key":"1344_CR9","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.identj.2022.11.008","volume":"73","author":"Q Yang","year":"2023","unstructured":"Yang Q, Sun Y, Qiu B, Zhao H. FBXW7 enhances cisplatin-induced apoptosis in oral cancer cell lines. Int Dent J. 2023;73:620\u20137. https:\/\/doi.org\/10.1016\/j.identj.2022.11.008.","journal-title":"Int Dent J"},{"key":"1344_CR10","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/kjm2.12888","volume":"40","author":"SY Qin","year":"2024","unstructured":"Qin SY, Li B, Liu JM, Lv QL, Zeng XL. LncRNA NR2F2-AS1 inhibits the progression of oral squamous cell carcinoma by mediating the miR-32-5p\/SEMA3A axis. Kaohsiung J Med Sci. 2024;40:877\u201389. https:\/\/doi.org\/10.1002\/kjm2.12888.","journal-title":"Kaohsiung J Med Sci"},{"key":"1344_CR11","doi-asserted-by":"publisher","first-page":"e706","DOI":"10.4317\/medoral.23729","volume":"25","author":"GM Gilligan","year":"2020","unstructured":"Gilligan GM, Panico RL, Di Tada C, Piemonte ED, Brunotto MN. Clinical and immunohistochemical epithelial profile of non-healing chronic traumatic ulcers. Med Oral Patol Oral Cir Bucal. 2020;25:e706\u201313. https:\/\/doi.org\/10.4317\/medoral.23729.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"1344_CR12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1600-0714.2010.00901.x","volume":"39","author":"ED Piemonte","year":"2010","unstructured":"Piemonte ED, Lazos JP, Brunotto M. Relationship between chronic trauma of the oral mucosa, oral potentially malignant disorders and oral cancer. J Oral Pathol Med. 2010;39:513\u20137. https:\/\/doi.org\/10.1111\/j.1600-0714.2010.00901.x.","journal-title":"J Oral Pathol Med"},{"key":"1344_CR13","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/odi.14527","volume":"30","author":"X Sheng","year":"2024","unstructured":"Sheng X, Li X, Qian Y, Wang S, Xiao C. ETS1 regulates NDRG1 to promote the proliferation, migration, and invasion of OSCC. Oral Dis. 2024;30:977\u201390. https:\/\/doi.org\/10.1111\/odi.14527.","journal-title":"Oral Dis"},{"key":"1344_CR14","doi-asserted-by":"publisher","first-page":"S274","DOI":"10.4103\/jpbs.JPBS_83_20","volume":"12","author":"KC Dash","year":"2020","unstructured":"Dash KC, Mahapatra N, Bhuyan L, Panda A, Behura SS, Mishra P. An immunohistochemical study showing Ki-67 as an analytical marker in oral malignant and premalignant lesions. J Pharm Bioallied Sci. 2020;12:S274\u20138. https:\/\/doi.org\/10.4103\/jpbs.JPBS_83_20.","journal-title":"J Pharm Bioallied Sci"},{"key":"1344_CR15","doi-asserted-by":"publisher","first-page":"997","DOI":"10.4103\/jcrt.JCRT_10_20","volume":"18","author":"S Swain","year":"2022","unstructured":"Swain S, Nishat R, Ramachandran S, Raghuvanshi M, Behura SS, Kumar H. Comparative evaluation of immunohistochemical expression of MCM2 and Ki67 in oral epithelial dysplasia and oral squamous cell carcinoma. J Cancer Res Ther. 2022;18:997\u20131002. https:\/\/doi.org\/10.4103\/jcrt.JCRT_10_20.","journal-title":"J Cancer Res Ther"},{"key":"1344_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11050872","volume":"11","author":"M Georgaki","year":"2021","unstructured":"Georgaki M, Avgoustidis D, Theofilou VI, et al. Recurrence in oral premalignancy: clinicopathologic and immunohistochemical analysis. Diagnostics. 2021;11:872. https:\/\/doi.org\/10.3390\/diagnostics11050872.","journal-title":"Diagnostics"},{"key":"1344_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814382","volume":"24","author":"L de Villala\u00edn","year":"2023","unstructured":"de Villala\u00edn L, \u00c1lvarez-Teijeiro S, Rodr\u00edguez-Santamarta T, et al. Emerging role of decoy receptor-2 as a cancer risk predictor in oral potentially malignant disorders. Int J Mol Sci. 2023;24:14382. https:\/\/doi.org\/10.3390\/ijms241814382.","journal-title":"Int J Mol Sci"},{"key":"1344_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-022-02188-0","volume":"22","author":"CL Wu","year":"2022","unstructured":"Wu CL, Huang CC, Wu SY, Jiang SS, Tsai FY, Hsiao JR. A new scoring system facilitating diagnosis of oral squamous malignancy on biopsy specimens. BMC Oral Health. 2022;22:165. https:\/\/doi.org\/10.1186\/s12903-022-02188-0.","journal-title":"BMC Oral Health"},{"key":"1344_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.job.2020.01.003","volume":"62","author":"M Ikeda","year":"2020","unstructured":"Ikeda M, Shima K, Kondo T, Semba I. Atypical immunohistochemical patterns can complement the histopathological diagnosis of oral premalignant lesions. J Oral Biosci. 2020;62:93\u20138. https:\/\/doi.org\/10.1016\/j.job.2020.01.003.","journal-title":"J Oral Biosci"},{"key":"1344_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.30476\/DENTJODS.2021.91032.1546","volume":"23","author":"N Akafzadeh","year":"2022","unstructured":"Akafzadeh N, Baghaei F, Derakhshan S, Moradzadeh Khiavi M, Kharazifard M, Aminishakib P. Combination of binary system with Ki67 immunohistochemical staining: a reliable grading method for oral epithelial dysplasia. J Dent (Shiraz). 2022;23:377\u201382. https:\/\/doi.org\/10.30476\/DENTJODS.2021.91032.1546.","journal-title":"J Dent (Shiraz)"},{"key":"1344_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/odi.13867","volume":"29","author":"B Embal\u00f3","year":"2023","unstructured":"Embal\u00f3 B, Miguel AFP, Konrath AC, Modolo F, Rivero ERC. Evaluation of two classification systems for oral epithelial dysplasia. Oral Dis. 2023;29:100\u20134. https:\/\/doi.org\/10.1111\/odi.13867.","journal-title":"Oral Dis"},{"key":"1344_CR22","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.pathol.2023.05.009","volume":"55","author":"JS Jeong","year":"2023","unstructured":"Jeong JS, Cho KJ, Lee HJ, Roh J, Lee YS, Song JS. Predictive modelling for the diagnosis of oral and laryngeal premalignant and malignant lesions using p53 and Ki-67 expression. Pathology. 2023;55:945\u201357. https:\/\/doi.org\/10.1016\/j.pathol.2023.05.009.","journal-title":"Pathology"},{"key":"1344_CR23","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.4103\/jcrt.JCRT_40_20","volume":"18","author":"A Bharti","year":"2022","unstructured":"Bharti A, Qayoom S, Jaiswal R, et al. Can dual staining with p16 and Ki67 be biomarkers of epithelial dysplasia in oral lesions? J Cancer Res Ther. 2022;18:1003\u20138. https:\/\/doi.org\/10.4103\/jcrt.JCRT_40_20.","journal-title":"J Cancer Res Ther"},{"key":"1344_CR24","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.31557\/APJCP.2020.21.7.2067","volume":"21","author":"AR Gadbail","year":"2020","unstructured":"Gadbail AR, Korde S, Chaudhary MS, et al. Ki67, CD105, and \u03b1-SMA expression supports biological distinctness of oral squamous cell carcinoma arising in the background of oral submucous fibrosis. Asian Pac J Cancer Prev. 2020;21:2067\u201374. https:\/\/doi.org\/10.31557\/APJCP.2020.21.7.2067.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1344_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261575","volume":"16","author":"PK Govindaraj","year":"2021","unstructured":"Govindaraj PK, Kallarakkal TG, Mohd Zain R, Tilakaratne WM, Lew HL. Expression of Ki-67, cornulin and ISG15 in non-involved mucosal surgical margins as predictive markers for relapse in oral squamous cell carcinoma (OSCC). PLoS ONE. 2021;16:e0261575. https:\/\/doi.org\/10.1371\/journal.pone.0261575.","journal-title":"PLoS ONE"},{"key":"1344_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.31557\/APJCP.2020.21.1.37","volume":"21","author":"M Nazar","year":"2020","unstructured":"Nazar M, Naz I, Mahmood MK, Hashmi SN. Immunohistochemical expression of cyclin D1 and Ki-67 in primary and metastatic oral squamous cell carcinoma. Asian Pac J Cancer Prev. 2020;21:37\u201341. https:\/\/doi.org\/10.31557\/APJCP.2020.21.1.37.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1344_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4103\/jomfp.jomfp_115_21","volume":"26","author":"S Karnam","year":"2022","unstructured":"Karnam S, Girish HC, Nayak VN. Senescent fibroblast in oral submucous fibrosis aids in disease progression and malignant transformation. J Oral Maxillofac Pathol. 2022;26:199\u2013207. https:\/\/doi.org\/10.4103\/jomfp.jomfp_115_21.","journal-title":"J Oral Maxillofac Pathol"},{"key":"1344_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/jop.13632","volume":"54","author":"L Monteiro","year":"2025","unstructured":"Monteiro L, Rocha E, Ferreira S, Salazar F, Pacheco JJ, Warnakulasuriya S. Tissue biomarkers for predicting the risk of oral cancer in patients diagnosed with oral leukoplakia: a systematic review of the past 4\u2009years. J Oral Pathol Med. 2025;54:283\u20139. https:\/\/doi.org\/10.1111\/jop.13632.","journal-title":"J Oral Pathol Med"},{"key":"1344_CR29","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.4317\/medoral.25298","volume":"27","author":"IG Segura","year":"2022","unstructured":"Segura IG, Secchi DG, Gal\u00edndez MF, et al. Connexin 43, Bcl-2, Bax, Ki67, and E-cadherin patterns in oral squamous cell carcinoma and its relationship with GJA1 rs12197797 C\/G. Med Oral Patol Oral Cir Bucal. 2022;27:e366\u201374. https:\/\/doi.org\/10.4317\/medoral.25298.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"1344_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4103\/jcrt.JCRT_508_20","volume":"18","author":"S Choudhari","year":"2022","unstructured":"Choudhari S, Masne S, Bhandare P, Dhumal S. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis. J Cancer Res Ther. 2022;18:55\u201365. https:\/\/doi.org\/10.4103\/jcrt.JCRT_508_20.","journal-title":"J Cancer Res Ther"},{"key":"1344_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.patol.2023.02.005","volume":"56","author":"E Escobar","year":"2023","unstructured":"Escobar E, G\u00f3mez-Valenzuela F, Pe\u00f1afiel C, Hormaz\u00e1bal-Hevia A, Herrera-Fuentes C, Mori-Aliaga D. Immunohistochemical expression of COX-2, Ki-67, Bcl-2, Bax, VEGF and CD105 according to histological grading in oral squamous cell carcinoma. Rev Esp Patol. 2023;56:147\u201357. https:\/\/doi.org\/10.1016\/j.patol.2023.02.005.","journal-title":"Rev Esp Patol"},{"key":"1344_CR32","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.6026\/973206300191405","volume":"19","author":"D Vala","year":"2023","unstructured":"Vala D, Mehta T, Arjun Gadakh M, Patel M, Mondal A, Gupta B. Expression analysis of cyclin D, Ki-67, MCM3 and MCM2 in oral squamous cell carcinoma. Bioinformation. 2023;19:1405\u201310. https:\/\/doi.org\/10.6026\/973206300191405.","journal-title":"Bioinformation"},{"key":"1344_CR33","doi-asserted-by":"publisher","first-page":"679","DOI":"10.4103\/jomfp.jomfp_262_23","volume":"27","author":"CC Apoorva","year":"2023","unstructured":"Apoorva CC, Ananthaneni A, Kumar AJ, Guduru VS, Puneeth HK. Evaluation of USP22 and Ki-67 expression in oral squamous cell carcinoma: an immunohistochemical study. J Oral Maxillofac Pathol. 2023;27:679\u201384. https:\/\/doi.org\/10.4103\/jomfp.jomfp_262_23.","journal-title":"J Oral Maxillofac Pathol"},{"key":"1344_CR34","doi-asserted-by":"publisher","DOI":"10.1177\/03946320241272527","volume":"38","author":"L Wang","year":"2024","unstructured":"Wang L, Jiang N, Lee Chen C. Correlation between human papillomavirus protein expression and clinicopathological features in oral squamous cell carcinoma. Int J Immunopathol Pharmacol. 2024;38:3946320241272527. https:\/\/doi.org\/10.1177\/03946320241272527.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1344_CR35","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/odi.13347","volume":"26","author":"C Xie","year":"2020","unstructured":"Xie C, Feng H, Zhong L, et al. Proliferative ability and accumulation of cancer stem cells in oral submucous fibrosis epithelium. Oral Dis. 2020;26:1255\u201364. https:\/\/doi.org\/10.1111\/odi.13347.","journal-title":"Oral Dis"},{"key":"1344_CR36","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/PAI.0000000000000876","volume":"29","author":"M P\u00e9rez-Say\u00e1ns","year":"2021","unstructured":"P\u00e9rez-Say\u00e1ns M, Lorenzo-Pouso AI, Chamorro-Petronacci CM, et al. Immunoexpression of apoptosis and cell-cycle arrest markers in oral lichen planus. Appl Immunohistochem Mol Morphol. 2021;29:374\u201381. https:\/\/doi.org\/10.1097\/PAI.0000000000000876.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"1344_CR37","doi-asserted-by":"publisher","first-page":"e719","DOI":"10.4317\/medoral.24511","volume":"26","author":"L Monteiro","year":"2021","unstructured":"Monteiro L, Silva P, Delgado L, et al. Expression of spindle assembly checkpoint proteins BubR1 and Mad2 expression as potential biomarkers of malignant transformation of oral leukoplakia: an observational cohort study. Med Oral Patol Oral Cir Bucal. 2021;26:e719\u201328. https:\/\/doi.org\/10.4317\/medoral.24511.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"1344_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1055\/s-0040-1721212","volume":"9","author":"K Mondal","year":"2020","unstructured":"Mondal K, Mandal R, Sarkar BC. Importance of Ki-67 labeling in oral leukoplakia with features of dysplasia and carcinomatous transformation: an observational study over 4 years. South Asian J Cancer. 2020;9:99\u2013104. https:\/\/doi.org\/10.1055\/s-0040-1721212.","journal-title":"South Asian J Cancer"},{"key":"1344_CR39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/mjdrdypu.mjdrdypu_18_20","volume":"14","author":"R Yadahalli","year":"2021","unstructured":"Yadahalli R, Kheur S, Reddy M, Gupta A. To correlate the immunohistochemical analysis of p16 and Ki-67 in oral squamous cell carcinoma with the background of oral submucous fibrosis. Med J DY Patil Vidyapeeth. 2021;14:26\u201330. https:\/\/doi.org\/10.4103\/mjdrdypu.mjdrdypu_18_20.","journal-title":"Med J DY Patil Vidyapeeth"},{"key":"1344_CR40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.31557\/APJCP.2020.21.1.157","volume":"21","author":"B Ahmad","year":"2020","unstructured":"Ahmad B, Asif M, Ali A, Jamal S, Khan MZ, Khadim MT. Expression of Ki-67 and \u03b2eta-catenin in pseudoepitheliomatous hyperplasia and squamous cell carcinoma in oral mucosal biopsies: an immunohistochemical study. Asian Pac J Cancer Prev. 2020;21:157\u201361. https:\/\/doi.org\/10.31557\/APJCP.2020.21.1.157.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1344_CR41","doi-asserted-by":"publisher","first-page":"795","DOI":"10.21037\/tcr.2019.12.08","volume":"9","author":"M Wo\u017aniak","year":"2020","unstructured":"Wo\u017aniak M, Nahajowski M, Hnitecka S, et al. A comparative study of osteopontin expression, Ki67 index and prognosis in squamous cell carcinoma and cysts of the oral cavity. Transl Cancer Res. 2020;9:795\u2013808. https:\/\/doi.org\/10.21037\/tcr.2019.12.08.","journal-title":"Transl Cancer Res"},{"key":"1344_CR42","first-page":"112","volume":"20","author":"S Khalesi","year":"2023","unstructured":"Khalesi S, Maleki L, Eskandari S, Dehabadi FZ, Kohpaee AY. Cyclin D1 and Ki-67 expression and its correlation with histopathological parameters and cervical lymph node metastasis in oral squamous cell carcinoma. Dent Res J (Isfahan). 2023;20:112.","journal-title":"Dent Res J (Isfahan)"},{"key":"1344_CR43","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38941","volume":"15","author":"V Gupta","year":"2023","unstructured":"Gupta V, Ramalingam K, Yasothkumar D, Debnath D, Sundar V. Ki-67 expression as a prognostic marker: a comparative immunohistochemical analysis of oral epithelial dysplasia and oral squamous cell carcinoma. Cureus. 2023;15:e38941. https:\/\/doi.org\/10.7759\/cureus.38941.","journal-title":"Cureus"},{"key":"1344_CR44","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.oooo.2019.09.019","volume":"129","author":"A Alsabbagh","year":"2020","unstructured":"Alsabbagh A, Robins TL, Harriman A, et al. Surrogate markers for high-risk human papillomavirus infection in oral epithelial dysplasia: A comparison of p16, Ki-67, and ProExC. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;129:246\u201359. https:\/\/doi.org\/10.1016\/j.oooo.2019.09.019.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1344_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.oor.2023.100109","volume":"8","author":"K Jot","year":"2023","unstructured":"Jot K, Nayyar V, Surya V, Roychoudhury A, Mishra D. Clinicopathological comparison and assessment of Ki67, p53 and c-myc immunoexpression in carcinoma cuniculatum, verrucous carcinoma and microinvasive squamous cell carcinoma of the oral cavity. Oral Oncol Rep. 2023;8:100109. https:\/\/doi.org\/10.1016\/j.oor.2023.100109.","journal-title":"Oral Oncol Rep"},{"key":"1344_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065816","volume":"24","author":"M Tarle","year":"2023","unstructured":"Tarle M, Ragu\u017e M, Muller D, Luk\u0161i\u0107 I. Nuclear epidermal growth factor receptor overexpression as a survival predictor in oral squamous cell carcinoma. Int J Mol Sci. 2023;24:5816. https:\/\/doi.org\/10.3390\/ijms24065816.","journal-title":"Int J Mol Sci"},{"key":"1344_CR47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2485\/jhtb.30.355","volume":"30","author":"J Ono","year":"2021","unstructured":"Ono J, Okada Y, Kanri Y, Sano H, Hasegawa H. Immunohistochemical study of differential expressions of CAR, E-Cadherin, CK-13, -17, p53 and Ki-67 in oral lichen planus, lichenoid lesion and lichenoid epithelial dysplasia. J Hard Tissue Biol. 2021;30:355\u201362. https:\/\/doi.org\/10.2485\/jhtb.30.355.","journal-title":"J Hard Tissue Biol"},{"key":"1344_CR48","doi-asserted-by":"publisher","DOI":"10.1590\/1678-7757-2020-0751","volume":"29","author":"AR Gadbail","year":"2021","unstructured":"Gadbail AR, Sarode SC, Chaudhary MS, et al. Ki67 labelling index predicts clinical outcome and survival in oral squamous cell carcinoma. J Appl Oral Sci. 2021;29:e20200751. https:\/\/doi.org\/10.1590\/1678-7757-2020-0751.","journal-title":"J Appl Oral Sci"},{"key":"1344_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/life11040336","volume":"11","author":"L Batelja-Vuletic","year":"2021","unstructured":"Batelja-Vuletic L, Tomasovic-Loncaric C, Ceppi M, et al. Comparison of androgen receptor, VEGF, HIF-1, Ki67 and MMP9 expression between non-metastatic and metastatic stages in stromal and tumor cells of oral squamous cell carcinoma. Life. 2021;11:336. https:\/\/doi.org\/10.3390\/life11040336.","journal-title":"Life"},{"key":"1344_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99326-5","volume":"11","author":"J Sundberg","year":"2021","unstructured":"Sundberg J, Pandey S, Giglio D, et al. Expression of p53, p63, podoplanin and Ki-67 in recurring versus non-recurring oral leukoplakia. Sci Rep. 2021;11:20781. https:\/\/doi.org\/10.1038\/s41598-021-99326-5.","journal-title":"Sci Rep"},{"key":"1344_CR51","doi-asserted-by":"publisher","DOI":"10.1590\/1678-7757-2019-0532","volume":"28","author":"IP Klein","year":"2020","unstructured":"Klein IP, Meurer L, Danilevicz CK, Squarize CH, Martins MD, Carrard VC. BMI-1 expression increases in oral leukoplakias and correlates with cell proliferation. J Appl Oral Sci. 2020;28:e20190532. https:\/\/doi.org\/10.1590\/1678-7757-2019-0532.","journal-title":"J Appl Oral Sci"},{"key":"1344_CR52","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/jop.13608","volume":"54","author":"K Li","year":"2025","unstructured":"Li K, Wang S, Li Z, et al. Prognostic value of Ki-67 in the invasive zone of oral squamous cell carcinoma. J Oral Pathol Med. 2025;54:173\u201381. https:\/\/doi.org\/10.1111\/jop.13608.","journal-title":"J Oral Pathol Med"},{"key":"1344_CR53","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.oooo.2023.03.005","volume":"135","author":"AFP Miguel","year":"2023","unstructured":"Miguel AFP, Poletto DAG, Embal\u00f3 B, Rivero ERC. Association between epithelial-mesenchymal transition markers, proliferative index, and oral epithelial dysplasia: an immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2023;135:904\u201313. https:\/\/doi.org\/10.1016\/j.oooo.2023.03.005.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1344_CR54","doi-asserted-by":"publisher","first-page":"S2555","DOI":"10.4103\/jpbs.jpbs_301_24","volume":"16","author":"D Das","year":"2024","unstructured":"Das D, Issac AS, Sangala BN, et al. Longitudinal study of oral precancerous lesions: Transformation rate and predictive markers for malignancy. J Pharm Bioallied Sci. 2024;16:S2555\u20137. https:\/\/doi.org\/10.4103\/jpbs.jpbs_301_24.","journal-title":"J Pharm Bioallied Sci"},{"key":"1344_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5430309","volume":"2022","author":"A Dafar","year":"2022","unstructured":"Dafar A, Siarov A, Mostaghimi Y, et al. Langerhans cells, T cells, and B cells in oral lichen planus and oral leukoplakia. Int J Dent. 2022;2022:5430309. https:\/\/doi.org\/10.1155\/2022\/5430309.","journal-title":"Int J Dent"},{"key":"1344_CR56","doi-asserted-by":"publisher","first-page":"242","DOI":"10.14715\/cmb\/2023.69.12.38","volume":"69","author":"S Aziz","year":"2023","unstructured":"Aziz S, Hamad S, Qasim Y. The expression of p53, ki67 and COX-2 in erosive-type oral lichen planus. Cell Mol Biol (Noisy-le-grand). 2023;69:242\u20137. https:\/\/doi.org\/10.14715\/cmb\/2023.69.12.38.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"1344_CR57","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s12105-021-01309-5","volume":"15","author":"N Sivakumar","year":"2021","unstructured":"Sivakumar N, Narwal A, Kamboj M, Devi A, Kumar S, Bhardwaj R. Molecular and immunohistochemical cognizance of HPV16 in oral leukoplakia, oral squamous cell carcinoma and oropharyngeal squamous cell carcinoma. Head Neck Pathol. 2021;15:882\u201392. https:\/\/doi.org\/10.1007\/s12105-021-01309-5.","journal-title":"Head Neck Pathol"},{"key":"1344_CR58","doi-asserted-by":"publisher","first-page":"253","DOI":"10.31557\/APJCP.2022.23.1.253","volume":"23","author":"KA Kamala","year":"2022","unstructured":"Kamala KA, Kanetkar SR, Datkhile KD, Sankethguddad S. Expression of Ki67 biomarker in oral submucous fibrosis with clinico-pathological correlations: a prospective study. Asian Pac J Cancer Prev. 2022;23:253\u20139. https:\/\/doi.org\/10.31557\/APJCP.2022.23.1.253.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1344_CR59","doi-asserted-by":"publisher","first-page":"272","DOI":"10.4103\/ijdr.ijdr_551_21","volume":"33","author":"KA Kamala","year":"2022","unstructured":"Kamala KA, Kanetkar SR, Datkhile KD, Sankethguddad S. Expression of Ki67 as potential biomarker in oral submucous fibrosis: an immunohistochemical study. Indian J Dent Res. 2022;33:272\u20136. https:\/\/doi.org\/10.4103\/ijdr.ijdr_551_21.","journal-title":"Indian J Dent Res"},{"key":"1344_CR60","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/JMAU.JMAU_28_19","volume":"8","author":"A Iqbal","year":"2019","unstructured":"Iqbal A, Tamgadge S, Tamgadge A, et al. Evaluation of Ki-67 expression in oral submucous fibrosis and its correlation with clinical and histopathological features. J Microsc Ultrastruct. 2019;8:20\u20134. https:\/\/doi.org\/10.4103\/JMAU.JMAU_28_19.","journal-title":"J Microsc Ultrastruct"},{"key":"1344_CR61","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2021\/51369.15702","volume":"15","author":"SG Bhat","year":"2021","unstructured":"Bhat SG, Kamath SM, Mysorekar VV. Correlation of BCL-2 and Ki67 expression with clinicopathological parameters in oral squamous cell carcinoma. J Clin Diagn Res. 2021;15:11. https:\/\/doi.org\/10.7860\/JCDR\/2021\/51369.15702.","journal-title":"J Clin Diagn Res"},{"key":"1344_CR62","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4103\/jomfp.jomfp_310_21","volume":"26","author":"NS Mohanapure","year":"2022","unstructured":"Mohanapure NS, Khandeparkar SGS, Saragade PB, Gogate BP, Joshi AR, Mehta SR. Immunohistochemical study of epidermal growth factor receptor, human epidermal growth factor receptor 2\/neu, p53, and Ki67 in oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2022;26:127\u20138. https:\/\/doi.org\/10.4103\/jomfp.jomfp_310_21.","journal-title":"J Oral Maxillofac Pathol"},{"key":"1344_CR63","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ajoms.2023.01.003","volume":"35","author":"H Takada","year":"2023","unstructured":"Takada H, Goto M, Fukumura M, Ishibashi K, Nakayama A, Okubo S, et al. Prognostic implications of FGFR3high\/Ki-67high in oral squamous cell carcinoma. J Oral Maxillofac Surg Med Pathol. 2023;35:495\u2013500. https:\/\/doi.org\/10.1016\/j.ajoms.2023.01.003.","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"key":"1344_CR64","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4103\/jomfp.jomfp_202_22","volume":"27","author":"S Rana","year":"2023","unstructured":"Rana S, Mondal P, Mandal M, Datta P, Maji I, Chakraborty J. Expression of stathmin in oral squamous cell carcinoma and its correlation with tumour proliferation. J Oral Maxillofac Pathol. 2023;27:103\u20138. https:\/\/doi.org\/10.4103\/jomfp.jomfp_202_22.","journal-title":"J Oral Maxillofac Pathol"}],"container-title":["Odontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10266-026-01344-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10266-026-01344-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10266-026-01344-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:11:50Z","timestamp":1772129510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10266-026-01344-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":64,"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.1007\/s10266-026-01344-0","relation":{},"ISSN":["1618-1247","1618-1255"],"issn-type":[{"value":"1618-1247","type":"print"},{"value":"1618-1255","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors disclosed no relevant relationships.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}